Naviswiss receives FDA clearance for hip navigation technology

The FDA gave Naviswiss FDA clearance for its navigation technology for hip replacement surgery, allowing the company to begin selling its products in all U.S. markets.

Advertisement

The clearance is for both primary replacement and revision hip replacement surgery. The technology works with several surgical approaches and available implants on the market.

Naviswiss now offers its products in the U.S., Europe, Australia and Asia.

More articles on surgery centers:
The ‘new normal’ for ASCs: 16 admins on how the pandemic will change the field forever
Dr. Thomas Vikoren: Same-day TJR ‘made all the more important’ by COVID-19
Indiana orthopedic practice with surgery center to open

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.